Evidence map›Paper›PMID 36721665›Full record

ArticleClinical ophthalmology (Auckland, N.Z.)2023

Terson Syndrome - Clinical Presentation, Management, and Visual Outcomes in a Tertiary Centre.

Mario Lima-Fontes, Mariana Leuzinger-Dias, Rita Rodrigues, Ricardo Barros-Pereira, Manuel Falcão, Vítor Fernandes, Pedro Alves-Faria, Fernando Falcão-Reis, Amândio Rocha-Sousa

Open access · goldAbstract read
In one paragraph

Article in Clinical ophthalmology (Auckland, N.Z.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
8.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Mario Lima-FontesOphthalmology Department, Centro Hospitalar Universitário São João, Porto, 4200-319, Portugal.ORCID 0000-0002-9126-3505
Mariana Leuzinger-DiasOphthalmology Department, Centro Hospitalar Universitário São João, Porto, 4200-319, Portugal.ORCID 0000-0002-9361-0195
Rita RodriguesOphthalmology Department, Centro Hospitalar Universitário São João, Porto, 4200-319, Portugal.
Ricardo Barros-PereiraOphthalmology Department, Centro Hospitalar Universitário São João, Porto, 4200-319, Portugal.
Manuel FalcãoOphthalmology Department, Centro Hospitalar Universitário São João, Porto, 4200-319, Portugal.ORCID 0000-0003-4718-0910
Vítor FernandesOphthalmology Department, Centro Hospitalar Universitário São João, Porto, 4200-319, Portugal.
Pedro Alves-FariaOphthalmology Department, Centro Hospitalar Universitário São João, Porto, 4200-319, Portugal.
Fernando Falcão-ReisOphthalmology Department, Centro Hospitalar Universitário São João, Porto, 4200-319, Portugal.
Amândio Rocha-SousaOphthalmology Department, Centro Hospitalar Universitário São João, Porto, 4200-319, Portugal.
Hospital de São João · PTUniversidade do Porto · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: The purpose of this study was to characterize the clinical presentation, management strategy and visual outcomes of patients diagnosed with Terson syndrome and followed in a tertiary centre in Portugal. Patients and Methods: A single-centre retrospective study was performed, based on the survey review of the medical records of every consecutive patient diagnosed with Terson syndrome and followed from January 2018 to August 2021. The change in best-corrected visual acuity (BCVA) from baseline to the final evaluation was the primary outcome. Results: Fifteen eyes from 8 patients (50% female) were included. The mean age at diagnosis was 55±7 years. The neurological event was traumatic brain injury in 37.5% (n=3) and subarachnoid haemorrhage in 62.5% of the patients (n=5). Bilateral intraocular haemorrhage occurred in 875% (n=7) of the patients. Vitreous and preretinal haemorrhages occurred each in 66.7% (n=10), intraretinal in 30% (n=3) and subretinal in 13.3% (n=2) of the eyes. In 40% of the eyes (n=6), spontaneous resolution of intraocular haemorrhage occurred, while PPV was performed in the remaining 60% (n=9). Ocular haemorrhage detection occurred 58.47 ± 40.94 days after the neurological event (range 11 to 121 days). Baseline BCVA was 1.11 ± 1.01 logMAR and improved to 0.32 ± 0.69 logMAR in the follow-up period (p=0.004). A positive correlation was found between initial and final BCVA (Spearman's rho = 0.643, p=0.01). Baseline BCVA of eyes undergoing PPV was lower than of those conservatively managed (1.84±0.72 vs 0.20±0.28 logMAR, p<0.001). However, there were no statistically significant differences in final BCVA after surgery or observation (0.56 ± 0.90 vs 0.04 ± 0.04 logMAR, p=0.149). Longer periods between the neurological and the ophthalmological diagnosis were correlated with worse final BCVA (Spearman's rho = 0.688, p=0.005). Conclusion: Terson syndrome is a potential cause of irreversible visual loss. Diagnosis delay may affect visual prognosis. PPV is indicated when intraocular haemorrhage is dense and does not resolve spontaneously or when visual acuity at presentation is low, allowing for good visual outcomes with minimal complications.

Indexed as

clinical presentationmanagementTerson syndromevisual outcomesvitrectomy

Identifiers

PMID36721665
PMCPMC9884450
OpenAlexW4318754947

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.